roof. The younger sediments are capped by several flowstones -calcite deposits produced inside caves by the action of water -that occur immediately below this remnant and have been dated by the uranium-series ( 230 Th) method to between about 28,000 and 108,000 years ago. The flowstones are in stratigraphic order, with the oldest at the bottom. Because they are continuous across the floor of the cave, they also prevented younger material from being introduced into the underlying deposits.
The human fossils were found below the oldest flowstone, and so they are about 100,000-113,000 years old, and possibly older. The associated faunal remains (of 21 large mammal species and 34 small ones) include some species now extinct in the region, such as the orang-utan (Pongo) and giant tapir (Megatapirus). Overall, 25% of the large mammals are extinct, and a late Middle Pleistocene age of the fauna is therefore consistent with the stratigraphic dating. The age and context of the human remains therefore seem sound.
Those remains consist of the front part of a mandible (lower jaw) and two molar teeth. The latter are small, and would be considered as modern in a Late Pleistocene west Eurasian (post-Neanderthal) sample, but there are insufficient east Asian specimens to show that they are unequivocally modern. Here, the mandible is the key piece of evidence. As described by Liu et al. 1 , this possesses characteristics seen in both early modern humans and late archaic ones; in China, these are referred to as either 'archaic Homo sapiens' or 'late Homo erectus' . Modern aspects of the mandible include a feature called the anterior symphysis; archaic aspects are the lingual symphysis, and the mandible's overall robustness compared with the gracile (lighter) build of younger, modernhuman ones.
The authors 1 interpret these characteristics as indicating that modern humans arrived in south China more than 100,000 years ago, and then interbred with the indigenous population. As they point out, this is incompatible with a scenario whereby an immigrant African population of modern humans totally replaced the local population, with no interbreeding.
Is it likely that modern humans entered China as early as 100,000 years ago? Most researchers would disagree: the earliest un equivocal evidence for modern humans from southeast Asia is a cranium from Niah Cave, Borneo, dated to around 40,000 years ago 6 , and the colonization of Australia by H. sapiens probably occurred no earlier than 50,000-60,000 years ago 4, 5 . Various estimates based on genetic analyses of modern populations suggest that H. sapiens first entered south Asia some 50,000-60,000 years ago 7 . However, an earlier exit is not impossible. We need to remember that there is no skeletal evidence for the Homo lineage between Borneo and East Africa over the time span 40,000-100,000 years ago, and so it is a major assumption that modern humans were absent from southern Asia at this time. On palaeoclimatic grounds (as well as proximity to East Africa), it seems unlikely that modern humans entered the Levant in the last interglacial, some 125,000-110,000 years ago, but not the Arabian Peninsula. Once in eastern Arabia, there would have been few barriers to their dispersal eastwards into India.
Recent evidence 8 from India indicates that, before 74,000 years ago (the age of the Toba eruption in Sumatra, Indonesia, ash from which forms a major marker horizon across India), stone-core-flaking techniques were similar to those from East Africa, and this implies that modern humans may already have been in India then. Some genetic analyses also suggest that modern humans were in south Asia before the Toba eruption 9 . Modern humans may therefore have entered southeast Asia earlier than currently thought.
All this is speculation until the requisite fossil evidence is found. 
Import and nuclear size
The size of a cell's nucleus is usually proportional to the size of the cell itself. How are the two linked? The answer lies, at least in part, in the import of one or more cytoplasmic cargoes into the nucleus.
O R N a C O h E N -F I x

I
t is rare to come across a basic question in cell biology that is almost entirely un resolved, but what determines the size of a cell or of an organelle is one such question 1 . Does the cell use a 'molecular ruler' to directly assess the size of its compartments, or does it use a surrogate, such as protein concentration, to determine how big its structures are? Reporting in Cell, Levy and Heald 2 provide evidence that at least partly answers these questions in regard to the size of the cell nucleus.
Regulation of nuclear size is perhaps one of the most striking, and enigmatic, examples of organelle-size control, because it is tightly linked to cell size 3 . Indeed, there is a constant ratio between nuclear and cell volumes (the N/C volume ratio), and deviations from it are associated with disease 4 . But how is this ratio regulated? To address this question, researchers have attempted 5, 6 to perturb the N/C volume ratio in yeast, but to no avail: neither nuclear-DNA content, nor varied growth conditions, nor drug treatments, could alter the ratio.
Another question is what aspect of cell volume affects nuclear size: is it the cell's entire volume; the volume of only the cytoplasm; or perhaps that of another organelle? In multinucleated fission yeast, the size of each nucleus is proportional to its surrounding cytoplasm 6 , but how the cytoplasm affects nuclear size, if at all, has remained unknown.
Levy and Heald 2 study regulation of nuclear size in two related frog species -Xenopus laevis and Xenopus tropicalis -that differ in both body size and the number of chromosome copies per cell (ploidy). Xenopus laevis is larger and its cells are tetraploid, whereas X. tropicalis is smaller and its cells are diploid. The two species also differ in another aspect: the cells and nuclei of X. laevis are larger.
An advantage of Xenopus as an experimental model is that its nuclei can be assembled in a test tube using the chromatin (DNA-protein complexes) and extracts of its egg cytoplasm. This allowed Levy and Heald 2 to ask, what is the main determinant of nuclear size in Xenopus: the DNA or a cytoplasmic factor?
The authors added sperm chromatin from either X. laevis or X. tropicalis to egg extracts from either X. laevis or X. tropicalis (Fig. 1a) . They found that, although both extracts can trigger assembly of the nuclear envelope around the chromatin, the X. laevis extract forms larger nuclei than the X. tropicalis extract, regardless of the DNA used. This indicates that one or more cytoplasmic factors determine nuclear size.
A hint of the underlying difference between the extracts from the two frog species came from the authors' analyses of nuclear importthe process by which proteins are transported into the nucleus 7 . Both the rate of nuclear import and the maximum size of the imported cargo were greater in the nuclei reconstituted with X. laevis extracts. The capacity for nuclear import therefore might be a regulator of nuclear size.
The two extracts differed in two proteins that mediate nuclear import -importin-α and Ntf2. In X. laevis extracts, the levels of importin-α were higher and those of Ntf2 lower than in X. tropicalis extracts. Indeed, when Levy and Heald added active (phosphorylated) importin-α to X. tropicalis extracts they observed an increase in nuclear size. The role of Ntf2 in regulating nuclear size is less straightforward. Nonetheless, X. tropicalis extracts supplemented with both active importin-α and an inhibitor of Ntf2 activity form nuclei that are similar in size to those formed in X. laevis extracts 2 (Fig. 1b) . That nuclear import affects nuclear size is perhaps not surprising, as a previous paper 8 showed that, in the absence of import, the nuclear envelope -which forms around the chromosomes at the end of mitotic cell division -fails to expand. But in showing that, at least in vitro, import is a limiting factor for nuclear growth, Levy and Heald's report provides a specific step that could be targeted for regulating nuclear size in vivo.
Which of the cargoes carried by importin-α are crucial for controlling nuclear size? From an engineering standpoint, enlarging a structure could require an extension of its underlying framework. Whether the nucleus has an internal framework -the 'nuclear matrix' -is debatable, but there is no doubt that the nuclear lamina serves as a framework supporting the nuclear envelope. Indeed, Levy and Heald found that the addition of lamin B3, a component of the nuclear lamina, to X. tropicalis extracts resulted in increased membrane is continuous with that of another organelle, the endoplasmic reticulum, the cell might regulate nuclear size by controlling the amount of endoplasmic-reticulum membrane that is allocated to the nucleus.
Nevertheless, geometry tells us that surface area increases at a slower rate than volume (surface area is a function of the radius squared, whereas volume is a function of the radius cubed). Intriguingly, a recent study 9 on the scaling of transcription with cell size in yeast revealed that, whereas expression of most genes increases in proportion to the increase in cell size, the expression of genes encoding cell-surface proteins lags behind. How this size-sensing mechanism works isn't clear, but it would be interesting to examine whether the abundance of proteins associated with nuclearenvelope expansion is also 'size-sensitive' .
Levy and Heald's results 2 uncover a process that affects nuclear size, providing a glimpse into a mechanism that may couple nuclear volume to cell volume. To fully understand the N/C volume ratio, researchers need biological tools -mutants and/or RNAi knockdownsthat perturb this ratio. So to anyone who thinks that all the interesting basic cell-biologi cal questions have been answered, here is one that is still wide open. ■ Orna Cohen-Fix is in the Laboratory of Molecular and Cellular Biology, nuclear size. Thus, nuclear import may regulate nuclear size through controlling the availability of nuclear-lamina components.
Neither yeast nor plants have lamins, which raises the question of how general is regulation of nuclear size by lamin import. Whether nuclear import itself affects nuclear size in yeast is unresolved 5, 6 , although at least one study 6 found that a prolonged inhibition of nuclear export increases nuclear volume by 50%. It could be, therefore, that nuclear size in yeast and plants also depends on nuclear import, not of lamin but of some other cargo.
The cell-free system Levy and Heald describe is remarkably useful for identifying proteins and processes that affect nuclear size. The next step will be to determine how such processes affect nuclear size within the cell, and whether they contribute to the N/C volume ratio. Levy and Heald did address this question by injecting importin-α into developing X. laevis embryos. They observed a transient increase in nuclear size in early stages of development, but whether cell volume is affected in any way remains unknown.
When considering the scaling of nuclear size with cell size, one must take into account the increase not only in volume, but also in surface area 4 . An influx of material through nuclear import could lead to physical stress that signals for an increase in the surface area of the nuclear envelope. Alternatively, because the nuclear 
Peptides as biological semiconductors
A simple peptide that assembles into desirable nanoscale structures is a striking example of how the whole can be greater than the sum of its parts. What's more, the assembly process is controllably reversible.
C h a R L O T T E a . E . h a u s E R & s h u G u a N G Z h a N G
C ould a simple, short peptide made of naturally occurring amino acids form structures that have the optical and electronic properties of semiconductor nanocrystals? Reporting in the Journal of the American Chemical Society, Gazit, Rosenman and colleagues 1 describe a peptide formed from just two phenylalanine amino acids that does exactly that. This is a remarkable discovery, because although conductive organic polymers are well known (their discoverers won the 2000 Nobel chemistry prize 2 ), no one had envisaged that biological peptides could act as semiconductors. The reported dipeptide assemblies 1 represent an intriguing, bioorganic class of 'quantum dot' nanomaterial.
A quantum dot is a nanoscale, ordered structure whose excitons -energy-carrying quasiparticles associated with semiconductors and insulators -are confined in three spatial dimensions. This means that quantum dots have electronic properties intermediate between those of bulk materials and discrete molecules. They are being used in solar cells, light-emitting devices and as fluorescent labelling agents in the biomedical industry.
Most quantum dots are made of inorganic semiconductors, often a single material such as silicon or germanium. Others are 'core-shell' structures, in which a semiconductor such as cadmium selenide (CdSe) or zinc sulphide (ZnS) is surrounded by another material. Such CdSe quantum dots have been particularly successful for a variety of applications, but the toxicity associated with cadmium is increasingly a concern. The search for cadmium-free quantum dots has therefore become a major area of research.
The phenomenon that constrains excitons in quantum dots is known as quantum confinement. A key feature of quantum confinement is that it occurs when the diameter of a particle is about the same size as the wavelength of the particle's electronic wavefunction. For objects made of materials that have highly ordered structures, this occurs at the nanoscale, independently of the material used. In other words, as long as there is quantum confinement, there is no reason that materials other than semiconductors -including peptides -cannot form quantum dots. Enter Gazit, Rosenman and colleagues 1 . They observed that when a solution of diphenyl alanine peptide in methanol is concentrated, the peptide molecules self-assemble into nano crystalline structures (Fig. 1) . These assemblies have an average diameter of 2.1 nanometres and consist of two diphenylalanine peptides, corresponding to a total of just four phenylalanine residues per assembly. The authors found that the peptide assemblies have the characteristic optical properties of quantum dots: on exciton formation, they emit light across a very narrow frequency range (that is, they have a narrow photo excitation peak). But when the authors studied low-concentration solutions of the dipeptide, which contain discrete dipeptide molecules rather than nanocrystalline assemblies, they observed a broad excitation peak. This suggests that individual dipeptide molecules are not quantum dots.
The peptide quantum dots have an intriguing property not found in inorganic quantum dots: when Gazit, Rosenman and colleagues changed the solvent in which the dipeptide nanostructures were dispersed from methanol to water, the structures underwent further self-assembly to form peptide nanotubes. The nanotube dispersion had near-identical optical properties and X-ray diffraction patterns to those of the quantum-dot dispersion, thus proving that the quantum dots are the elementary, quantum-confined building blocks of the nanotubes.
Diphenylalanine-peptide nanotubes have been reported before. Their observed rigidity seems to be very high 3 , they are piezoelectric 4 (they generate charge under mechanical strain) and they have been used as scaffolds to fabricate silver nanowires 5 . Gazit and Rosenman's groups have also previously observed quantum confinement in peptide nanostructures 6 , and have demonstrated that diphenylalanine peptides can assemble to form quantum wells (structures in which excitons are confined within two dimensions) that exhibit strong blue luminescence 7 . But the present paper 1 is the first to describe the elementary quantum-confined structures that underpin the earlier findings.
What makes this result even more interesting is that the self-assembly of the peptide quantum dots into nanotubes is completely reversible -the nanotubes disassembled back to individual quantum dots when the authors changed the dispersion solvent from water to 1 report that when they concentrated a solution of diphenylalanine peptides in methanol, the molecules self-assembled into quantum dots. Each quantum dot was composed of two diphenylalanines. b, When the authors changed the solvent from methanol to water, the peptides further self-assembled to form nanotubes, each containing millions of quantum dots. The nanotube assembly process was completely reversible -when the solvent was changed back to methanol, the nanotubes disassembled into individual quantum dots.
